2022
DOI: 10.3389/fcimb.2022.767083
|View full text |Cite
|
Sign up to set email alerts
|

Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Haemophilus influenzae Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children

Abstract: BackgroundNontypeable Haemophilus influenzae (NTHi) is the most common bacterial otopathogen associated with otitis media (OM). NTHi persists in biofilms within the middle ears of children with chronic and recurrent OM. Australian Aboriginal children suffer exceptionally high rates of chronic and recurrent OM compared to non-Aboriginal children. NTHi protein vaccines comprised of antigens associated with both adhesion and persistence in a biofilm are under development and could be beneficial for children with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 46 publications
0
3
0
Order By: Relevance
“…Idiopathic SSNHL does spontaneously resolve in 45%-65% of patients, however controversy remains on potential etiologies and best course of treatment (Conlin and Parnes, 2007;Kuhn et al, 2011). such as Amoxicillin, but vaccination against common middle ear pathogens such as S. pneunomiae and H. influenzae has become standard practice in some countries (Martinovich et al, 2021;Clark et al, 2022;Izurieta et al, 2022). The treatment of CSOM remains a clinical challenge and often requires the combination of oral antibiotics, eardrops, and surgery due to the presence of antibiotic-resistant bacteria and bacterial biofilm (Mittal et al, 2018;Leach et al, 2021).…”
Section: Idiopathic Sudden Sensorineural Hearing Lossmentioning
confidence: 99%
“…Idiopathic SSNHL does spontaneously resolve in 45%-65% of patients, however controversy remains on potential etiologies and best course of treatment (Conlin and Parnes, 2007;Kuhn et al, 2011). such as Amoxicillin, but vaccination against common middle ear pathogens such as S. pneunomiae and H. influenzae has become standard practice in some countries (Martinovich et al, 2021;Clark et al, 2022;Izurieta et al, 2022). The treatment of CSOM remains a clinical challenge and often requires the combination of oral antibiotics, eardrops, and surgery due to the presence of antibiotic-resistant bacteria and bacterial biofilm (Mittal et al, 2018;Leach et al, 2021).…”
Section: Idiopathic Sudden Sensorineural Hearing Lossmentioning
confidence: 99%
“…[29][30][31] Assessing natural responses in children to these highly conserved, but clinically relevant proteins, we saw that otitis-prone children, and in particular Australian Aboriginal otitis-prone children, had reduced antibody responses when compared to non-otitisprone children. 28,32 Together these data highlight the need to better understand the differences in protein expression and develop appropriate disease models to identify suitable vaccine candidates to both prevent and resolve chronic diseases such as OM. These future strategies also need to take into account the polymicrobial nature of this disease.…”
Section: Immune Mediated Prevention or Treatment Of Om Biofilmsmentioning
confidence: 99%
“… 132 Australian Aboriginal otitis-prone children had lower serum IgG titres to major NTHi vaccine candidate antigens (rsPilA, ChimV4 and outer membrane protein 26), suggesting that Aboriginal children may benefit from immunisation with vaccines containing these antigens to increase titres of protective antibodies. 133 There are also other NTHi surface dominant antigens that can be used as candidate vaccine molecules. However, unlike capsular type H. influenzae , NTHi lacks a single surface antigen and may require a multi component binding targeted vaccine.…”
Section: H Influenzae Vaccine Preventionmentioning
confidence: 99%